Drug intelligence / Profile preview

platelet poor plasma gel

Development stage: Phase 1
Modality: Adoptive Cell Transfer → Cell Therapies
Administration: Intradermal, Injection, Local Implantation

Overview

Platelet poor plasma gel (PPP gel) is a blood-derived biomaterial prepared from platelet-poor plasma through heating (typically at 75-90°C) or chemical cross-linking methods. It forms a stable, fibrin-rich material with enhanced consistency and volume without utilizing the intrinsic coagulation pathway. PPP gel serves as an autologous dermal filler for facial rejuvenation and has applications in regenerative medicine as a carrier for bioactive substances and as a scaffolding material.

Other names: PPP gelalbumin gelplasma gel

Beyond the preview

Go deeper on platelet poor plasma gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on platelet poor plasma gel.

Explore the full profile